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Abstract 
Increasing estradiol concentrations during the late follicular phase stimulate sexual 
behavior and the GnRH/LH surge, and it is known that kisspeptin signaling is 30 
essential for the latter. Administration of LPS can block these events, but the 
mechanism involved is unclear. We examined brain tissue from intact ewes to 
determine: i) which regions are activated with respect to sexual behavior, the LH 
surge and LPS administration, ii) the location and activation pattern of kisspeptin 
cells in control and LPS treated animals, and iii) whether CRFR type 2 is involved in 35 
such disruptive mechanisms. Follicular phases were synchronized with progesterone 
vaginal pessaries and control animals were killed at 0h, 16h, 31h or 40h (n=4-
6/group) after progesterone withdrawal (time zero). At 28 h, other animals received 
endotoxin (LPS; 100 ng/kg) and were subsequently killed at 31h or 40h (n=5/group). 
LH surges only occurred in control ewes, during which there was a marked increase 40 
in c-Fos expression within the ventromedial nucleus (VMN), arcuate nucleus (ARC), 
medial preoptic area (mPOA), as well as an increase in the percentage of kisspeptin 
cells co-expressing c-Fos in the ARC and mPOA compared to animals sacrificed at all 
other times. Expression of c-Fos also increased in the bed nucleus of the stria 
terminalis (BNST) in animals just before the expected onset of sexual behavior. 45 
However, LPS treatment increased c-Fos expression within the VMN, ARC, mPOA and 
diagonal band of broca (dBb), along with CRFR type 2 immunoreactivity in the lower 
part of the ARC and median eminence (ME), compared to controls. Furthermore, the 
percentage of kisspeptin cells co-expressing c-Fos was lower in the ARC and mPOA. 
Thus, we hypothesize that in intact ewes, the BNST is involved in the initiation of 50 
sexual behavior while the VMN, ARC, mPOA as well as kisspeptin cells located in the 
latter two areas are involved in estradiol positive feedback only during the LH surge. 
By contrast, disruption of sexual behavior and the LH surge after LPS involves cells 
located in the VMN, ARC, mPOA and dBb, as well as cells containing CRFR type 2 in 
the lower part of the ARC and ME, and is accompanied by inhibition of kisspeptin cell 55 
activation in both the ARC and mPOA.  
 
 
Introduction 
In the late follicular phase, decreasing progesterone and increasing estradiol 60 
concentrations trigger the onsets of sexual behavior and the GnRH/LH (gonadotropin 
releasing hormone/luteinizing hormone) surges (1). However, sudden activation of 
the hypothalamic-pituitary-adrenal axis by an immune/inflammatory challenge, in 
the form of E. coli lipopolysaccharide (LPS), lowers plasma estradiol concentrations 
and delays the onsets of sexual behavior and the LH surge of intact ewes via 65 
unknown mechanisms (2). 
In the normal follicular phase, it is generally accepted that the major feedback 
effects of estradiol on GnRH secretion occur indirectly. Estradiol acts upon estradiol-
receptive neurons, located in the hypothalamus/preoptic area (POA; 3-4), with axons 
that project directly and/or indirectly to GnRH neurons (5). However, the precise 70 
location and cell phenotypes involved at different stages of the follicular phase 
remain unknown with respect to either change in sexual behavior or GnRH secretion. 
A possible scenario is that alterations in the progesterone:estradiol balance could 
influence cellular activation patterns in specific brain areas during progressive stages 
of the follicular phase. Monitoring the presence of c-Fos (a marker for neuronal 75 
activation; 6) would pinpoint the location of activated cells involved in sexual 
behavior and GnRH/LH surge generating mechanisms. By contrast, we hypothesize 
that the physiological activation patterns are altered by LPS, and c-Fos will also 
reveal the regions through which this stressor acts to disrupt the follicular phase.  
 80 
A plethora of recent studies provide evidence that the hypothalamic neuropeptide 
kisspeptin is essential for GnRH/LH surge release across a large number of species (7-
8). In the ewe, kisspeptin has been implicated in mediating estradiol negative (9) and 
positive feedback (10-12), as well as orchestrating GnRH/LH pulsatility (8) and surge 
secretion (10-15). However, the pattern of kisspeptin cell activation in both main 85 
populations of cells (ARC and mPOA) during the whole course of the follicular phase 
has not yet been investigated. Interestingly, in addition to steroid hormones, 
kisspeptin neurons have been proven sensitive to the actions of various stressors, 
including LPS, and are likely to operate as transmitters for effects on GnRH neurons 
(16). Specifically, a few studies in female rats report reduced levels of kisspeptin 90 
mRNA and suppression of the reproductive axis after a challenge with LPS (17-18). To 
date, there are no studies addressing the potential alterations of kisspeptin cell 
activation (at peptide level) in key hypothalamic nuclei during acute inflammatory 
stress in any species. Given the crucial role of kisspeptin in regulating GnRH 
secretion, we hypothesize that stress-induced suppression of reproductive 95 
parameters is accompanied by a failure of kisspeptin cell activation. 
 
Regarding the potential mechanisms involved in the disruption  of sexual behavior 
and GnRH/LH patterns after LPS, various studies suggest that a common pathway for 
the action of stressors is to stimulate the cellular activity of the paraventricular 100 
nucleus (PVN), especially neurons secreting corticotropin releasing factor (CRF; 18-
20). In the rat, CRF has a pivotal role in stress-induced suppression of GnRH pulses 
and is thus a prime candidate for transmitting the ‘stress’ signal to GnRH cells 
directly or via interneurons (21). Li et al., (22) report that LPS involves the activation 
of Type 2 but not Type 1 CRF receptor (CRFR) to mediate inhibitory actions. 105 
However, the importance of CRFR has not been extensively investigated in the ewe.  
In the present study we examined brain tissue from intact ewes sacrificed at various 
times during the follicular phase with or without the administration of LPS. We used 
c-Fos to locate the brain areas that exhibit activation events before or during the 
onset of sexual behavior, during the LH surge or after LPS and may, therefore, be 110 
involved in the physiological and/or pathological mechanisms. Furthermore, we 
aimed to map the pattern of kisspeptin cell activation (by measuring co-expression 
with c-Fos; 6) in the ARC and mPOA at various times during the follicular phase, as 
well as testing the hypothesis that the LH surge disruption after the application of 
LPS is associated with inhibition of kisspeptin cell activation. Finally, we examined 115 
the presence of CRFR Type 2 in the ARC and ME to establish whether up-regulation 
of this particular receptor may play a role in the LH surge inhibition after stress.  
 
Materials and Methods  
Animals, study design and blood sampling procedure 120 
The study was performed in the mid-breeding season (October/November) on 30 
mature intact Lleyn crossbred ewes. From two weeks prior to the study, the ewes 
were penned altogether indoors (space 15 x 7 meters) with the same 3 experienced 
teaser rams present throughout, to avoid spurious behavioural activity. Frequent 
handling for at least a week ensured that the animals were acclimatized to human 125 
contact. All procedures were conducted within requirements of the UK Animal 
(Scientific Procedures) Act, 1986, and approved by the University of Liverpool Animal 
Welfare Committee. 
Ovarian follicular phases were synchronized with two intravaginal progesterone-
releasing pessaries (Controlled Internal Drug Release [CIDR-G]; InterAg, Hamilton, 130 
New Zealand) for nine days and an intramuscular (i.m.) injection of prostaglandin 
(Lutalyse, 5 mg/ewe, Pharmacia & Upjohn, UK) 12 h before, and a second injection, 
at CIDR-G removal. The time of progesterone withdrawal (i.e., commencement of 
the follicular phase) is referred to hereafter as time 0 h.   
The experimental protocol is outlined in Fig.1. The ewes were randomly allocated to 135 
six groups. One group was killed at 0 h (0 h control group; n=5) and another group at 
16 h after progesterone withdrawal (16 h control group; n=4). At 28 h, the remaining 
animals received 2 ml saline vehicle or endotoxin (Lipopolysaccharides from 
Escherichia coli 055:B5, LPS, Sigma-Aldrich, UK; i.v. dose of 100 ng/kg body weight). 
The LPS dose is routinely used in our studies and evokes a robust cortisol increase 140 
and attenuation of the LH surge without other undue clinical effects (2). The timing 
of the treatments was chosen in order to precede all sexual behaviors and not just 
mounting. Two groups were killed at 31h (31h control, n=6 and 31h LPS group, n=5) 
and two groups at 40h after progesterone withdrawal (40h control, n=5 and 40h LPS 
group, n=5).   145 
 
Frequent blood sampling, as well as the administration of all substances, was 
facilitated by insertion of a silastic catheter into the jugular vein of each ewe under 
local anesthesia before progesterone withdrawal. Patency was maintained with 
heparinized saline (Multihep, 100 iu/ml, Leo Laboratories, Princes Risborough, UK) 150 
after each blood withdrawal. Blood samples (5 ml at 0h, 16h, 24h and subsequently 
at 2h intervals till 40h) were collected and centrifuged immediately at 1000 g for 20 
min at 40C. Plasma was stored at -200C until analysis. Samples, in duplicate, were 
analyzed by Enzyme-Linked Immunosorbent Assays (ELISAs) for LH, pregnane 
metabolites (equivalent to, and hereafter referred to as, progesterone) or cortisol. 155 
These assays were performed with methods adapted from (23-25), respectively. 
LH results were expressed as ng equivalent of NIAMDD ovine LH 21 per ml plasma. 
Estradiol was measured with a modified radioimmunoassay (RIA) using 0.5 ml 
plasma extracted with 3 ml diethyl ether followed by evaporation to dryness. All 
assays were verified for use in sheep (26). Contemporary inter-assay and intra-assay 160 
coefficients of variation for LH, progesterone, cortisol and estradiol were all less than 
12%.  The minimum detectable amounts were 0.02 ng/ml; 0.16 ng/ml, 0.8 ng/ml and 
0.2 pg/ml and assay precisions (in the mid-range of the standard curve) were 0.1 
ng/ml, 0.01 ng/ml, 0.2 ng/ml and 0.2 pg/ml, respectively. All samples from individual 
animals were measured in the same assay for each hormone.  165 
Visual observation of sexual behavior 
Ewe and ram sexual behavior was recorded by two trained observers for a 30-minute 
observation period prior to each blood sample collection. The observers were placed 
in an elevated position to assist efficient monitoring of the entire pen where the 
animals were allowed to move freely. Once a minute throughout each observation 170 
period, it was noted if a ewe was within one meter of a ram [behavioral scan 
sampling; Martin and Bateson (27)]. In addition, the following behavioral signs were 
noted throughout each 30 min observation period: ram nosing the perineal region of 
the ewe; ewe being nudged by the ram without moving away; and, mounting of the 
ewe by the ram without moving away. Due to the 2-hourly observation regime, the 175 
beginning/end of periods were, respectively, defined as the first/last (minus/plus 
1.0h) 30-min observation period the animal exhibited a particular behavioral sign.  
Tissue collection 
Euthanasia was carried out with 20 ml 20% w/v sodium pentobarbitone 
(Pentobarbital, Loveridge, Southampton, UK), containing 25,000IU heparin. The 180 
solutions used for perfusion were: 2 liters 0.1M phosphate buffer (PB; pH7.4) 
containing 25,000IU per liter of heparin and 1% sodium nitrate; then 2 liters Zamboni 
fixative (4% paraformaldehyde) and 7.5% saturated picric acid in 0.1M PB, pH7.4); 
followed by 500ml of the same fixative containing 30% sucrose. The brain was left 
within the skull for a further 4h and then 500ml wash–out solution (0.1M PB, 40% 185 
sucrose and 0.1% sodium azide) was pumped through. Hypothalamic blocks were 
obtained and then frozen using isopentane (2-Methylbutane, Chromasolv®, for HPLC, 
Sigma-Aldrich, UK) and liquid nitrogen as described by Rosene et al., (28) and stored 
at -800C. Frozen coronal sections (40 μm) were cut using a freezing microtome 
(Microm HM400R, Walldorf, Germany). Free-floating sections were stored in 190 
cryoprotectant solution (29) and stored at -200C until processed for 
immunohistochemistry. 
c-Fos and kisspeptin dual-label immunohistochemistry  
A series of every 15th section (600μm intervals) through the preoptic area and 
mediobasal hypothalamus was processed using a dual-immunoperoxidase protocol 195 
in which nuclear c-Fos was detected first with nickel sulfate-enhanced 
diaminobenzidine as chromogen (ni-DAB; black), followed by detection of 
cytoplasmic kisspeptin using unenhanced diaminobenzidine (DAB; brown). All steps 
were performed at room temperature unless otherwise stated. Antibodies were 
diluted with 2.5% normal donkey serum (catalogue item S2170, Biosera, UK), 1% 200 
Triton X-100 (T9284, Sigma-Aldrich, UK) and 0.25% sodium azide (Sigma- Aldrich, UK) 
in 0.1M phosphate buffer saline, pH7.2 (PBS). Free-floating sections were washed 
thoroughly in PBS for 2h to remove the cryoprotectant solution followed by a 15min 
incubation in 40% methanol and 1% hydrogen peroxide (H2O2; 316989, Sigma-
Aldrich, UK) in PBS  to inactivate endogenous peroxidases. After three 10min washes, 205 
sections were incubated for 1h in blocking solution (10% donkey serum in PBS). This 
was followed by 72h incubation in rabbit anti-c-Fos antibody (AB-5, PC38, 
Calbiochem, Cambridge, MA, USA; 30) at 1:5000 at 40C. After incubation with 
primary antiserum, sections were washed thoroughly and incubated with 
biotinylated donkey anti-rabbit IgG (1:500; 711-065-152, Jackson Immunoresearch, 210 
West Grove, PA) for 2h, followed by three 10min washes and then 90min in 
Vectastain Elite ABC kit (1:250 in PBS; PK6100, Vector Laboratories Ltd, UK). After 
repeating washes, nuclear c-Fos was visualized by 5min incubation in ni-DAB (SK-
4100, Vector Laboratories Ltd, UK). A second immunohistochemical procedure was 
then performed, as described above, using rabbit anti-kisspeptin serum (1:25,000; 215 
lot 564; gift from Prof. Alain Caraty, Nouzilly, France; 31), incubated for 72h at 40C 
and then visualized using DAB. Negative control sections were performed routinely 
by omitting primary antibody(s). This resulted in complete loss of staining.  
CRFR Type 2 single-label immunohistochemistry  
For CRFR Type 2 (1:4000; ab12964; Abcam UK; 32) three sections, 240μm apart, 220 
containing the ARC and ME were chosen and a staining protocol performed as 
described above. The exclusion of the primary or secondary antibody resulted in 
complete absence of staining. 
Data analysis 
Hormone, behavior and immunohistochemistry data were analyzed with Minitab® 15 225 
statistical package (MINITAB Inc, Pennsylvania, USA). Results are expressed as mean 
± SEM, and for all analyses, statistical significance was regarded when P<0.05.  An LH 
surge was defined as a sustained increase (>4h) in LH plasma concentrations and 
onset was considered when the first value increased more than ten times the 
minimum detectable concentration (i.e., >10 ng/ml). Cortisol, progesterone and 230 
estradiol concentrations were compared between groups, per hour, with a general 
linear model (GLM) ANOVA followed by Tukey’s multiple comparisons post hoc test, 
when appropriate. In addition, because of considerable variation, progesterone 
concentrations at 28h (i.e., just prior to treatment) were compared within groups to 
the two mean consecutive maximum values recorded after treatment with a 235 
Wilcoxon sign rank test. 
 
Sections were examined using a microscope (Nikon Microscope, Eclipse 80i) and 
photographed with a Nikon camera using a 20× objective. The areas examined were 
[as defined by Welento et al., (33); Fig 6G-I ]: the VMN (4 photographs per section, 6 240 
sections per ewe), ARC (3 photographs per section, 10 sections per ewe, which 
consisted sections from the rostral, middle and caudal divisions of the nucleus), ME 
and bed nucleus of the stria terminalis (BNST; 1 photograph per section, 6 sections 
per ewe, for both areas), mPOA (2 photographs per section, 5 sections per ewe), 
diagonal band of Brocca (dBb; 2 photographs per section, 3 sections per ewe) and 245 
the PVN (1 photograph per section, 6 sections per ewe). CRFR Type 2 data were 
derived from 3 photographs that included the lower part of the ARC and the ME. 
Data from these two areas were combined due to the confined location of the 
receptors; i.e., on the ‘border’ either side of the ARC and ME boundary. All 
photographs were imported into Image J version 1.42q, and counts performed using 250 
the cell count plug-in. The observer was unaware of the animal identity and group. 
The mean total number and percentage of single- or dual-labeled cells was summed 
from the photographs of each area/section and then averaged for each ewe and 
compared with GLM ANOVA followed, where appropriate, by Tukey’s multiple 
comparisons post hoc test. Means (±SEM), as presented in figures and results, were 255 
calculated by averaging mean values from ewes in each group.  
 
Results 
Two animals exhibited estrus and were mounted by a ram within 28h after 
progesterone withdrawal (i.e., before the predetermined time of treatment; one 260 
from each of the 31h LPS and 40h LPS groups). The data from these two ewes were 
excluded from further analyses. None of the animals showed any signs of illness, 
with a few exceptions of mild coughing and briefly increased respiration rate for the 
ewes that received LPS.  
Plasma hormone profiles: Estradiol, Progesterone and Cortisol 265 
In control animals, plasma estradiol concentrations continued to increase from 28h 
after PW to maximum values between 32h and 36h after PW (Fig 2A). However, after 
treatment with LPS, estradiol concentrations tended to be lower than controls 8h 
after treatment (i.e., at 36h after PW; P<0.07; Fig.2A) and, thereafter, continued to 
decrease significantly until ewes were killed at 40h (P<0.02; Fig 2A). 270 
All groups had similar plasma progesterone concentrations at 0h and 28h after PW 
(33.7 ± 2.0 ng/ml and 6.6 ± 0.4 ng/ml, respectively). There was considerable 
between-animal variation, and values between treated and control groups were not 
different at each time point after treatment; therefore, a within-group comparison 
was also made. Within-group controls had similar concentrations of progesterone 275 
before and after treatment (Fig. 2B). Progesterone concentrations were different 
within the 40h LPS group, increasing from 6.9 ± 1.0 ng/ml to a mean maximum of 9.9 
± 1.6 ng/ml after treatment (P<0.05; Fig. 2B).  Progesterone concentrations after PW 
within control animals are also shown in Fig. 2A. 
In all control animals, mean plasma cortisol concentrations remained low throughout 280 
(10.5 ± 0.7 ng/ml; Fig. 2C). Before the application of LPS (i.e., at 24 and 28h after 
PW), cortisol concentrations did not differ from values in controls (Fig. 2C). At 30h, 
both groups of LPS animals had higher values compared to control groups (P<0.001; 
Fig. 2C). In the 40h LPS group, ewes had increased concentrations compared to the 
controls from 32h to 40h after PW (P<0.05 for all; Fig. 2C). Mean maximum cortisol 285 
concentrations (157 ± 19.8 ng/ml) for the LPS groups were observed 2h after 
treatment (Fig. 2C).  
Luteinising hormone (LH) and behavioral profiles. 
The onset of sexual behavior and the LH surge of individual ewes with respect to 
progesterone withdrawal (PW) are shown in Table 1. Control animals began 290 
exhibiting sexual behavior at 28.5 ± 2.4 h, and three of the five animals in the 40h-
control group had an LH surge with a mean onset at 36.7 ± 1.3 h (Table 1). Three of 
the eight LPS treated animals exhibited sexual behavior, whereas none of the treated 
animals began an LH surge during 40h of study (Table 1). Subsequent data were 
analyzed in two ways: the first consisted of only control ewe data, grouped according 295 
to time after PW, and incorporating sexual behavioral status and whether an LH 
surge had occurred; i.e., those killed: at 0h and 16h after PW; at 31h after PW but 
before the onset of sexual behavior (Before sexual behavior, n=3); at 31h or 40h 
after PW and during exhibition of sexual behavior but before an LH surge (During 
sexual behavior, n=5); or after the onset of sexual behavior and during the LH surge 300 
(Surge, n=3). This grouping was used to pinpoint the location of cells involved in 
sexual behavior and GnRH/LH surge generating mechanisms in control animals. 
Secondly, control and treated animal data were grouped according to time of killing 
after PW, and this was used to compare treatment effects. 
 305 
Control ewes grouped according to sexual behavior and the LH surge. 
 
 c-Fos activation  
The number of c-Fos positive cells in the VMN and mPOA was three times greater, 
and in the ARC four times greater, in the ‘Surge’ group compared to all other stages 310 
in the follicular phase of control ewes (P<0.05 for all comparisons; Fig 3A,B,C).  
The number of c-Fos positive cells in the ME and dBb was not different at any stage 
(Fig 3D and 3E). However, the number of c-Fos positive cells in the BNST was three 
times greater in the ‘Before sexual behavior’ group (P<0.001 for all comparisons; Fig 
3F).  315 
Kisspeptin distribution and c-Fos co-expression  
Kisspeptin immunoreactive cell bodies and fibers were found in anatomical 
structures as defined by Welento et al., (33) and similar to those in previous reports 
(31): i.e., the rostral, but primarily medial and caudal ARC, extending to the pre-
mammillary recess; the mPOA at the level of the organum vasculosum of the lamina 320 
terminalis; and the PVN (~ 30 cells per section and numerous fibers). A small number 
of scattered kisspeptin positive cells and fibers were detected alongside the third 
ventricle walls, the VMN and the dorsomedial hypothalamus but this was not 
consistent in all animals. A few kisspeptin cells (~ 5-10 cells per section) were 
observed in the ME internal zone, along with a dense fiber network, but this was less 325 
dense in the external zone. No kisspeptin cells were observed in the dBb or the 
BNST.  
The number of kisspeptin cells that co-expressed c-Fos in the ARC and mPOA 
increased in the ‘Surge’ group compared to all other stages in the follicular phase of 
control ewes (P<0.05 for both; Fig 4A and 4B).  330 
Comparison of control and LPS treated ewes  
c-Fos activation 
At 31h and 40h after PW (i.e., 3h and 12h after LPS administration, respectively), 
there was a marked increase in the number of c-Fos positive cells in the VMN of LPS 
treated ewes, compared to controls (P<0.05; Fig 5A).  335 
At 31h after PW, there was a marked increase in the number of c-Fos positive cells in 
the ARC of LPS treated ewes (P<0.01; Fig 5B) compared to controls. At 40h after PW, 
when the majority of control animals were undergoing an LH surge, control and LPS 
group data were not different (Fig 5B). 
At 31h after PW, the number of c-Fos positive cells in the mPOA increased in the LPS 340 
group (P<0.03; Fig 5C) compared to controls. At 40h after PW, when the majority of 
control animals were undergoing an LH surge, control and LPS data were not 
different (Fig 5C). 
The number of c-Fos positive cells in the ME and BNST was not altered by LPS (Fig 5D 
and 5F). However, at 31h and 40h after PW (i.e., 3h and 12h after treatment) LPS 345 
groups had markedly increased numbers of c-Fos positive cells in the dBb compared 
to controls (P<0.05; Fig 5E). 
 Kisspeptin and c-Fos co-expression  
The total number of kisspeptin positive cell bodies varied among animals but was not 
altered with the application of LPS (Table 2).  350 
In the ARC and mPOA at 31h after PW (i.e., 3h after LPS administration), the 
percentage of kisspeptin cells that co-expressed c-Fos in the LPS group was not 
different to controls (Fig 6A and 6B). However, at 40h after PW (i.e., 12h after LPS), 
the percentage of kisspeptin cells that co-expressed c-Fos was markedly lower in LPS 
treated animals compared to controls in both areas (P<0.01; Fig 6A and 6B). 355 
Photomicrographs of sections of the ARC in control and LPS treated animals are 
shown in Fig 6C-F, with an indication of the areas taken and considered for analysis 
in Fig 6G-I. 
c-Fos activation in the PVN and CRFR type 2 in the lower part of the ARC and ME. 
The number of c-Fos positive cells in the PVN was not different between all control 360 
groups (Fig 7A). A marked increase in c-Fos positive cells was observed in the PVN 
after LPS treatment (31h and 40h LPS groups; P<0.05 for both times; Fig 7A and 7B) 
compared to control groups.  
Immunohistochemistry revealed CRFR type 2 immunoreactivity in the lower part of 
the ARC, as well as the internal zone of the ME. At cellular level, the receptors had a 365 
‘ring-like’ morphology and were cytoplasmic in nature (Fig 7D). There was no 
difference in the number of CRFR type 2 cells between control animals (Fig 7C). 
However, LPS increased CRFR type 2 immunoreactivity in the lower ARC + ME 
(P<0.001; Fig 7C). This was evident at 31h and 40h after PW.  
 370 
Discussion 
The LH surge (and not earlier stages of the follicular phase) of intact ewes was 
accompanied by an intense cellular activation within the VMN, ARC and mPOA, as 
well as an activation of kisspeptin cells located in the ARC and mPOA. This suggests 
that the above hypothalamic regions as well as both major populations of kisspeptin 375 
cells contribute to estradiol positive feedback to stimulate the GnRH/LH surge in the 
ewe. By contrast, LPS treatment in the late follicular phase was accompanied by: a) 
disruption of the LH surge, b) intense cellular activation within the VMN, ARC, mPOA, 
PVN and dBb at different times compared to controls, c) failure of kisspeptin cells to 
be activated in the ARC and mPOA, and d) an increase in CRFR Type 2 380 
immunoreactivity in the lower part of the ARC and ME. The results of the present 
study extend our knowledge of the GnRH/LH surge mechanism, and its disruption 
after stress, by demonstrating that the patterns of cellular activation in the 
hypothalamus during the course of the follicular phase or following an acute stressor 
differ in a region and time specific manner. 385 
Cellular activation during the follicular phase of controls. 
Estradiol implants in the mediobasal hypothalamus (MBH; the vicinity of the ARC and 
VMN) initiated sexual behavior and the GnRH surge (3-4), whereas the mPOA, dBb 
and ME are areas rich in ERα (34) and/or GnRH cell perikarya and fibers (35). 
Therefore, these hypothalamic regions are all prime candidates for the control of 390 
follicular phase events.  We detected a marked activation within the VMN, ARC and 
mPOA during the LH surge compared to all other stages in the natural follicular 
phase. As the GnRH surge generating mechanism consists of three phases 
(activation, transmission and surge secretion; 36), our results suggest that cells 
located in the VMN, ARC and mPOA are activated only in the surge secretion phase 395 
and presumably facilitate GnRH neurosecretion at that time. This concurs with 
Richter et al., (37) who examined ovariectomized (OVX) animals during the activation 
phase of the surge generating mechanism as well as during surge onset. They also 
found greater activation of the ARC and mPOA in the latter stage but not the former.  
By contrast, the onset of sexual behavior did not cause any region-specific changes in 400 
hypothalamic c-Fos expression. However, an increase in BNST activation was 
observed in animals just before the expected onset of sexual behavior. Indeed, the 
BNST is an ERα-rich area (38) that receives projections from the cortical and medial 
nuclei of the amygdala which, in the ewe, are involved in the processing of olfactory 
information relevant to social recognition (39) and also sends projections to the 405 
mPOA where most GnRH cells are located (40-41). The BNST could, therefore, be an 
intermediary between the amygdala and the mPOA, transmitting pheromonal signals 
to GnRH neurons for the initiation of sexual behavior. It must be noted that the lack 
of activation in the key areas examined prior to the GnRH surge and sexual behavior 
does not exclude their involvement in the generation mechanism of these events. It 410 
may be that the phenotype of activated cells changes to stimulate sexual behavior 
and the GnRH surge, even though the overall number of c-Fos activated cells remains 
the same. Interestingly, at the time when estradiol was reaching maximum 
concentrations, activation was low in all the above areas. In this aspect, it would be 
of great interest to determine the activation pattern of ERα-containing neurons 415 
during the follicular phase which may reveal different cellular activation patterns.  
Kisspeptin cell activation during the follicular phase of controls. 
In the ewe, there are contradictory results concerning which of the two main 
populations of kisspeptin cells (the ARC or the mPOA) are involved in positive 
estradiol feedback (11, 15). This discrepancy between results may be due to the use 420 
of ovariectomized or intact animals with high doses of supplementary estradiol that 
could produce different c-Fos activation patterns than are normally seen in intact 
animals with physiological estradiol concentrations. In the present study, the LH 
surge of intact ewes was accompanied by an intense activation of kisspeptin neurons 
in both the ARC and mPOA. Regarding the ARC, all regions (rostral, middle and 425 
caudal) contributed equally to the increase. This, together with the observation that 
estradiol acts in the MBH to induce the GnRH/LH surge in the ewe (3-4), indicates 
that ARC kisspeptin cells are involved in estradiol positive feedback to stimulate 
GnRH/LH surges. However, as the estradiol signal initiating the GnRH surge begins 
well in advance of the surge itself (36), we cannot conclude that ARC kisspeptin cells 430 
are solely responsible for the feedback effects of estradiol, but are most likely only 
involved in the surge secretion mechanism. Nevertheless, we cannot ignore the 
possibility that activation in ARC kisspeptin neurons may have occurred at other 
times than those we examined in the present study; or the 11% of ARC kisspeptin 
cells that were activated prior to the surge were sufficient to transmit the positive 435 
estradiol signal to GnRH neurons.  
Turning to the mPOA, we observed a gradual increase in kisspeptin activation during 
the follicular phase with maximum activation during the surge. Two recent studies 
also report an increase in c-Fos activity of the mPOA kisspeptin cells at the time of 
the preovulatory LH surge (15) and an increase in kisspeptin mRNA in the late 440 
follicular phase (11). However, as mentioned above, in the ewe, there is evidence to 
show that estradiol acts in the MBH, not the POA, to induce the LH surge (3-4) so we 
speculate that mPOA kisspeptin neurons are activated secondarily (possibly via the 
ARC) during estradiol positive feedback.  
Kisspeptin has also been implicated in estradiol negative feedback (9). In our study, 445 
kisspeptin activation remained low during the follicular phase except at the time of 
the LH surge. One way of interpreting these results is that a low level of estradiol 
inhibits the expression of kisspeptin, leading to reduced GnRH secretion, consistent 
with negative feedback regulation.  
Cellular activation after LPS. 450 
In the present study, LPS administration in the late follicular phase lowered estradiol 
plasma concentrations and activated specific brain areas. Interestingly, an increase in 
activation was observed in the ARC, VMN, mPOA, PVN and dBb as early as 3h after 
treatment, whereas estradiol decreased 8h after the administration of LPS. Our 
results concur with evidence suggesting that there are at least two mechanisms 455 
activated in the hypothalamus during LPS inhibition of the ovarian cycle; one 
involving disruption of GnRH/LH pulses and, therefore, reducing estradiol secretion; 
and the other, preventing the ability of the surge-generating mechanism to respond 
to the preovulatory estradiol increase (42). Collectively, these results suggest that 
LPS acts within the ARC, VMN, mPOA, PVN and dBb to activate cells that inhibit the 460 
positive feedback effects of estradiol and, therefore, block the GnRH/LH surge. A 
similar mechanism may exist for the inhibition of sexual behavior. The precise 
phenotype of activated cells remains to be elucidated, however, strong evidence 
from the rat suggests that LPS administration stimulates the synthesis of γ-
aminobutyric acid (GABA; 43), and this activation could account for an important 465 
inhibiting mechanism for the disruption of the LH surge and/or sexual behavior after 
LPS.  
Kisspeptin cell activation after LPS. 
LPS markedly decreased the proportion of activated kisspeptin cells in the ARC and 
mPOA, and this was evident 12h after treatment, at a time when control animals 470 
were exhibiting an LH surge. Our data provide evidence for the potential existence of 
multiple kisspeptin cell inhibiting pathways. Firstly, as LPS is known to attenuate 
GnRH/LH pulses (42) and lower estradiol concentrations (2; and the present study), 
as well as the fact that kisspeptin cells are regulated by steroids (9, 11, 14), it may be 
that the failure of kisspeptin cells to become activated reflects the lack of a sufficient 475 
estradiol signal. In this regard, both cortisol and progesterone suppress pulsatile 
GnRH/LH secretion (44-46) and were elevated after the administration of LPS. 
Secondly, there are numerous signaling pathways activated by LPS that may 
influence kisspeptin cells directly. Our data indicate that there are a large number of 
cells activated in the hypothalamus/POA and these could provide inhibitory inputs to 480 
kisspeptin cells. We also found an increase in CRFR Type 2 immunoreactivity in the 
lower part of the ARC and the ME immediately after LPS, presumably in response to 
an intense activation in the PVN, where CRF cells are located (47). In rats, CRF 
administration i.c.v. profoundly decreases kisspeptin and kisspeptin receptor mRNA 
levels in both the anteroventral periventricular nucleus (AVPV) and ARC (18). 485 
Whether kisspeptin cells contain CRFRs remains to be investigated in any species. 
However, the kisspeptin and CRFR Type 2 distributions overlap and, therefore, 
interactions between the two systems seem likely.  Certainly, CRFR Type 2 appears 
to be involved in LPS induced disruption of the LH surge. Similarly, cortisol and 
progesterone have been implicated in the disruption of the positive feedback effect 490 
of estradiol to trigger an LH surge (37, 48-50). Progesterone achieves this by directly 
preventing the activation of estradiol-responsive cells in the hypothalamus/POA (37), 
and therefore, it is likely that this includes kisspeptin cells.  By contrast, evidence for 
a hypothalamic effect in cortisol disrupting the surge mechanism is lacking. However, 
glucocorticoid receptors Type 2 are abundant in the ARC and POA of the ewe (51) 495 
where kisspeptin cells are located; co-localization between the two components 
merits specific investigation.   
Conclusion 
Our results extend current knowledge regarding the mechanisms that control sexual 
behavior and the GnRH/LH surge, as well as their disruption after acute 500 
immune/inflammatory stress. We report that the LH surge of intact ewes is 
accompanied by an intense activation within the VMN, ARC and mPOA, as well as an 
activation of kisspeptin cells located in the ARC and mPOA. Taking into account that 
the GnRH surge mechanism consists of three phases (activation, transmission and 
surge secretion), our results indicate that these hypothalamic regions, as well as 505 
both major populations of kisspeptin cells, are involved only in the surge secretion 
phase.  Therefore, the cells that become activated prior to the LH surge when 
estradiol concentrations are initially elevated remain to be phenotyped. The BNST 
was activated just before the expected onset of sexual behavior and based on 
current neuroanatomical data we hypothesize that this may reflect the transmission 510 
of pheromonal signals from the amygdala. By contrast, acute LPS treatment 
prevented the LH surge from occurring and kisspeptin cells were not activated. This 
was accompanied by cellular activation in specific hypothalamic regions and an 
increase in CRFR Type 2 immunoreactivity in the lower part of the ARC and the ME. 
Both these mechanisms appear to be involved in the stress-induced disruption of the 515 
LH surge. The phenotype of the activated cells in response to LPS merit specific 
investigation.  
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Fig.1 Diagram of the experimental protocol (a) before and (b) after the onset of the follicular 
phase. CNTR = control; LPS = E. coli lipopolysaccharide 
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Fig. 2 A) Mean (±SEM) plasma estradiol concentrations in 40h control (■; n=5) and 40h LPS (●; n=4) groups. Mean (±SEM) plasma progesterone concentrations in 40h 
control animals (×; n=5) during the follicular phase are also shown for comparison with estradiol profiles. # Time at which 40h LPS group tended to differ from the 40h 
control group (P<0.07). *Time at which 40h LPS group differed from the 40h control group (P<0.02). B) Mean (±SEM) plasma progesterone concentrations at 28h after 
PW (before treatment; grey bars) and two mean (±SEM) consecutive maximum concentrations recorded after treatment (black bars), in the 31h control (31h CNTR; 
n=5), 31h LPS (n=4), 40h control (40h CNTR; n=5), and 40h LPS (n=4) groups. Due to the considerable between-animal variation, a within-group comparison was made. 
The differences between concentrations within an animal are linked by the line (* P<0.05). C) Mean (±SEM) cortisol concentrations in 31h control (♦; n=6), 31h LPS (o; 
n=4), 40h control (■; n=5) and 40h LPS (●; n=4) groups. * Time at which cortisol values from all treated groups were differed from the control groups (P<0.003). ** Time 
at which 40h LPS group values differed from the control group  (P<0.05). The arrows indicate time of treatment. Some error bars are within the data symbols. 
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Fig. 3 A) Mean (±SEM) number of c-Fos positive nuclei in the PVN of control ewes, B) photomicrographs of the PVN 
stained for c-Fos (black arrows) and kisspeptin (black arrow heads) in an LPS treated ewe. Scale bar 50 μm. C) 
Mean (±SEM) number of CRFR type 2-positive cells in the lower part of the ARC and ME, D) Immunohistochemically 
identified CRFR type 2-positive cells (black arrows) in the lower part of the ARC and ME (Scale bar: 20 μm). Animals 
are grouped according to time after PW i.e. control ewes at 0h, 16h, 31h and 40h (n=4-5 per group; black bars) as 
well as after LPS at 31h and 40h (n=4 for both times; grey bars). Treatment with saline or LPS was at 28h after PW 
(indicated by dashed arrow).  * P<0.05 compared to control groups.  
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Fig. 2 Mean (±SEM) number of c-Fos positive nuclei in the A) VMN, B) ARC, C) mPOA, D) ME, E) dBb and F) BNST, at 
different stages in the follicular phase of control ewes. Animals were grouped according to time as well as 
hormonal and behavioural status; i.e., grouped into those killed at 0h and 16h after PW (n=4-5), those killed at 31h 
or 40h after PW but before the onset of sexual behaviour and the LH surge (Before sexual behaviour, n=3), those 
killed at 31h or 40h after PW, during sexual  behaviour but before the LH surge onset (During sexual behavior, n=5) 
and those killed after the onset of both sexual behaviour and during the LH surge (Surge, n=3).* P<0.05 compared 
to all other stages in the follicular phase. 
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Fig. 5 Mean (±SEM) number of c-Fos positive nuclei in the A) VMN, B) ARC, C) mPOA, D) ME, E) dBb and F) BNST, at 
different times during the follicular phase of control and treated ewes. Animals are grouped according to time 
after PW i.e. control ewes at 0h, 16h, 31h and 40h (n=4-5 per group; black bars) as well as after LPS at 31h and 40h 
(n=4 for both times; grey bars). Treatment with saline or LPS was at 28h after PW (indicated by dashed arrow). Fig 
5A:* P<0.05 compared to controls. Fig. 5B and 5C: * P<0.05 compared to 0h, 16h, 31h controls. Fig 5E: * P<0.05 
compared to control and insulin subgroups combined. 
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Fig. 3 Mean (±SEM) % number kisspeptin cells that co-express c-Fos in the ARC A) and B) and mPOA C) and D) during the follicular phase of intact ewes. Animals 
in A and C are grouped according to time as well as hormonal and sexual behavioural status; see legend for Fig 2. In B and D animals are grouped according to 
time after PW i.e. control ewes at 0h, 16h, 31h and 40h (n=4-5 per group; black bars) as well as after LPS at 31h and 40h (n=4 for both times; grey bars 
Treatment with LPS was at 28h after progesterone withdrawal (indicated by dashed arrow).  *P<0.05 compared to all other groups within each panel. E-H) 
Photomicrographs of the ARC nucleus that were dual-labelled for kisspeptin cells and their co-expression with c-Fos in control animals during the LH surge (E 
and F) as well as 12 h after LPS treatment in the late follicular phase (G and H). The right panels in each section are the higher magnifications (20 μm) of the 
boxed areas shown in the left panels (50 μm). Black arrows indicate examples of dual-labelled cells, and white arrows indicate single-labelled kisspeptin-
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positive cells. I-K) Schematic diagrams illustrating the photographs (grey box) taken and considered for analysis in each area. AC: anterior commissure, dBb: 
diagonal band of broca, BNST: bed nucleus of the stria terminalis, mPOA: medial preoptic area, OC: optic chiasm, PVN: paraventricular nucleus, VMN: 
ventromedial nucleus, ARC: arcuate nucleus, ME: median eminence, 3V: third ventricle. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1 Time of the onset of the LH surge, pre-copulatory behavior and estrus (hours after PW) of individual ewes treated with saline or LPS at 28h after PW. 
Ewes were killed at 0h, 16h, 31h (31h control and 31h LPS groups) or 40h (40h control and 40h LPS groups) after PW. There was no sexual behaviour or LH 
surge recorded in control ewes killed at 0h or 16h.   
 
 Near Ram Being nosed Being nudged Mounted LH surge  
 
31h CNTR 
     
Sheep B      
Sheep C      
Sheep D 25 27 27   
Sheep E 26 26    
Sheep F      
Sheep P 25 25    
31h LPS       
Sheep Z      
Sheep Δ 27 27 29 29  
Sheep Я      
Sheep Ω      
40h CNTR  
     
Sheep H 38 38 38   
Sheep I 40 36 40 40  
Sheep K 24 24 28 32 38 
Sheep L 22 22 34 34 38 
Sheep M 28 30 30 30 34 
40h LPS  
     
Sheep T 26 26    
Sheep θ      
Sheep®      
Sheep Ξ 34 34 34 34  
      
 
